923 related articles for article (PubMed ID: 7873915)
21. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services.
O'Brien SF; Yi QL; Fan W; Scalia V; Kleinman SH; Vamvakas EC
Transfusion; 2007 Feb; 47(2):316-25. PubMed ID: 17302779
[TBL] [Abstract][Full Text] [Related]
22. Risk factors for prevalent and incident HIV infection in a cohort of volunteer blood donors in Harare, Zimbabwe: implications for blood safety.
McFarland W; Mvere D; Katzenstein D
AIDS; 1997 Sep; 11 Suppl 1():S97-102. PubMed ID: 9376107
[TBL] [Abstract][Full Text] [Related]
23. Current good manufacturing practice for blood and blood components; notification of consignees and transfusion recipients receiving blood and blood components at increased risk of transmitting hepatitis C virus infection ("lookback"). Final rule.
Food and Drug Administration, HHS
Fed Regist; 2007 Aug; 72(164):48765-801. PubMed ID: 17886394
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis C lookback in Canada.
Goldman M; Long A
Vox Sang; 2000; 78 Suppl 2():249-52. PubMed ID: 10938962
[TBL] [Abstract][Full Text] [Related]
25. Current good manufacturing practices for blood and blood components: notification of consignees receiving blood and blood components at increased risk for transmitting HIV infection--FDA. Final rule.
Fed Regist; 1996 Sep; 61(175):47413-23. PubMed ID: 10160337
[TBL] [Abstract][Full Text] [Related]
26. Horizontal versus vertical transmission of human immunodeficiency virus type 1 (HIV-1). Experience from southwestern Saudi Arabia.
al-Nozha MM; al-Frayh AR; al-Nasser M; Ramia S
Trop Geogr Med; 1995; 47(6):293-5. PubMed ID: 8650743
[TBL] [Abstract][Full Text] [Related]
27. HIV transmission through transfusion --- Missouri and Colorado, 2008.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 Oct; 59(41):1335-9. PubMed ID: 20966896
[TBL] [Abstract][Full Text] [Related]
28. Papua New Guinea Red Cross Blood Transfusion Service: present status and future considerations.
Tozer RA
P N G Med J; 1996 Mar; 39(1):38-42. PubMed ID: 9522849
[TBL] [Abstract][Full Text] [Related]
29. Laboratory strategic defense initiatives against transmission of human immune deficiency virus in blood and blood products.
Ahmed SG
Niger Postgrad Med J; 2003 Dec; 10(4):254-9. PubMed ID: 15045022
[TBL] [Abstract][Full Text] [Related]
30. Blood safety & prevalence of transfussion transmissible viral infections among donors at the Red Cross Blood Bank in Gondar University Hospital.
Diro E; Alemu S; G/Yohannes A
Ethiop Med J; 2008 Jan; 46(1):7-13. PubMed ID: 18711984
[TBL] [Abstract][Full Text] [Related]
31. Infectivity of pre-seroconversion donations: an analysis of lookback exercises in The Netherlands, 2000-2006.
Lieshout-Krikke RW; van 't Ende EA; Slot E; Karomi S; Kivit RM; Zaaijer HL
Vox Sang; 2012 Apr; 102(3):193-7. PubMed ID: 21883273
[TBL] [Abstract][Full Text] [Related]
32. Risk behaviors in volunteer blood donors who seroconverted for HIV, Abidjan, Côte d'Ivoire 1997 to 2005.
Minga A; Dohoun L; Abo Y; Coulibaly A; Konaté S; Ouattara HP; N'guessan BK; Dabis F; Salamon R; Lewden C;
Transfusion; 2010 Apr; 50(4):888-93. PubMed ID: 19951316
[TBL] [Abstract][Full Text] [Related]
33. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
[TBL] [Abstract][Full Text] [Related]
34. Profile of transfusion transmissible infections and associated risk factors among blood donors of Kerala.
Mathai J; Sulochana PV; Satyabhama S; Nair PK; Sivakumar S
Indian J Pathol Microbiol; 2002 Jul; 45(3):319-22. PubMed ID: 12785175
[TBL] [Abstract][Full Text] [Related]
35. Human immunodeficiency virus type 1 incidence among blood donors in France, 1992 through 2006: use of an immunoassay to identify recent infections.
Pillonel J; Barin F; Laperche S; Bernillon P; Le Vu S; Brunet S; Thierry D; Desenclos JC;
Transfusion; 2008 Aug; 48(8):1567-75. PubMed ID: 18482193
[TBL] [Abstract][Full Text] [Related]
36. The value of lookback to understanding blood-borne infectious diseases: the New South Wales' HIV experience.
Learmont JC; Phillips RS; Bickerton IJ
Transfus Med Rev; 2002 Oct; 16(4):315-24. PubMed ID: 12415517
[TBL] [Abstract][Full Text] [Related]
37. [Routine PCR screening for HBV, HCV and HIV-I genome in a large blood donation services--experiences and initial results].
Schottstedt V; Tuma W; Bünger G; Lakenberg P
Beitr Infusionsther Transfusionsmed; 1997; 34():21-5. PubMed ID: 9417342
[TBL] [Abstract][Full Text] [Related]
38. The natural history of transfusion-associated infection with human immunodeficiency virus. Factors influencing the rate of progression to disease.
Ward JW; Bush TJ; Perkins HA; Lieb LE; Allen JR; Goldfinger D; Samson SM; Pepkowitz SH; Fernando LP; Holland PV
N Engl J Med; 1989 Oct; 321(14):947-52. PubMed ID: 2779617
[TBL] [Abstract][Full Text] [Related]
39. [HIV prevalence and HIV incidence in blood donors in Baden-Württemberg].
Maurer C; Kiehl W; Altmann D
Beitr Infusionsther; 1993; 31():5-9. PubMed ID: 7693264
[TBL] [Abstract][Full Text] [Related]
40. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
